Public database on pharmaceutical ties in Japan: Traffic and user attitudes on industry-professional relationships

IF 3.4 3区医学 Q1 HEALTH POLICY & SERVICES

Health Policy and Technology Pub Date : 2024-06-01 DOI:10.1016/j.hlpt.2024.100847

Yosuke Suzuki , Anju Murayama , Akihiko Ozaki , Hiroaki Saito , Toyoaki Sawano , Erika Yamashita , Tetsuya Tanimoto

{"title":"Public database on pharmaceutical ties in Japan: Traffic and user attitudes on industry-professional relationships","authors":"Yosuke Suzuki , Anju Murayama , Akihiko Ozaki , Hiroaki Saito , Toyoaki Sawano , Erika Yamashita , Tetsuya Tanimoto","doi":"10.1016/j.hlpt.2024.100847","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>It is imperative to understand the specific details of the usage of the databases documenting financial ties between pharmaceutical companies and the healthcare sector and the attitudes of such database in evaluating how the citizens would recognize this issue. This study aimed to elucidate usage patterns and user attitudes regarding value transfers by analyzing data from the Yen For Docs Database in Japan (YDJ).</p></div><div><h3>Methods and Materials</h3><p>The study spanned the entire available data period, from January 15, 2019, to May 24, 2021, using Google Analytics to extract YDJ visitor data, including details on unique users, sessions, page views, and access paths over time. All visitors were invited to participate in a questionnaire survey gauging their attitudes towards value transfers from pharmaceutical firms to healthcare professionals. The survey data were analyzed separately for distinct groups, including non-healthcare or industry respondents, healthcare professionals, and those affiliated with pharmaceutical companies.</p></div><div><h3>Results</h3><p>YDJ received 604,903 accesses from 354,863 unique users, viewing 5,635,087 pages. Usage spiked initially and at later points. A survey of 399 respondents revealed negative views on value transfers from pharmaceutical companies, with over half finding it unethical. More than two-thirds supported stricter regulations. Non-healthcare respondents were less favorable compared to healthcare professionals and those affiliated with pharmaceutical companies.</p></div><div><h3>Conclusion</h3><p>YDJ achieved substantial user engagement, and the embedded questionnaire survey revealed prevalent critical perspectives among users regarding value transfers from pharmaceutical companies to the healthcare sector. Non-healthcare or industry respondents, in particular, expressed the most negative views about such relationships.</p></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Policy and Technology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2211883724000108","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}

引用次数: 0

Abstract

Background

It is imperative to understand the specific details of the usage of the databases documenting financial ties between pharmaceutical companies and the healthcare sector and the attitudes of such database in evaluating how the citizens would recognize this issue. This study aimed to elucidate usage patterns and user attitudes regarding value transfers by analyzing data from the Yen For Docs Database in Japan (YDJ).

Methods and Materials

The study spanned the entire available data period, from January 15, 2019, to May 24, 2021, using Google Analytics to extract YDJ visitor data, including details on unique users, sessions, page views, and access paths over time. All visitors were invited to participate in a questionnaire survey gauging their attitudes towards value transfers from pharmaceutical firms to healthcare professionals. The survey data were analyzed separately for distinct groups, including non-healthcare or industry respondents, healthcare professionals, and those affiliated with pharmaceutical companies.

Results

YDJ received 604,903 accesses from 354,863 unique users, viewing 5,635,087 pages. Usage spiked initially and at later points. A survey of 399 respondents revealed negative views on value transfers from pharmaceutical companies, with over half finding it unethical. More than two-thirds supported stricter regulations. Non-healthcare respondents were less favorable compared to healthcare professionals and those affiliated with pharmaceutical companies.

Conclusion

YDJ achieved substantial user engagement, and the embedded questionnaire survey revealed prevalent critical perspectives among users regarding value transfers from pharmaceutical companies to the healthcare sector. Non-healthcare or industry respondents, in particular, expressed the most negative views about such relationships.

查看原文本刊更多论文

日本医药关系公共数据库：交通和用户对行业与专业关系的态度。

研究背景了解记录制药公司与医疗保健部门之间财务关系的数据库的具体使用细节以及这些数据库在评估公民如何认识这一问题时所持的态度是非常必要的。本研究旨在通过分析日本Yen For Docs数据库（YDJ）的数据，阐明用户对价值转移的使用模式和态度。研究方法和材料本研究跨越了从2019年1月15日到2021年5月24日的整个可用数据期，使用Google Analytics提取YDJ访客数据，包括独立用户、会话、页面浏览量和访问路径的详细信息。我们邀请所有访问者参与问卷调查，以了解他们对制药公司向医疗保健专业人员转移价值的态度。调查数据按不同的群体分别进行了分析，包括非医疗保健或行业受访者、医疗保健专业人员以及制药公司的附属人员。结果YDJ 收到了来自 354,863 位独立用户的 604,903 次访问，浏览了 5,635,087 个页面。最初和后来的使用量都激增。对 399 名受访者进行的调查显示，他们对制药公司的价值转移持负面看法，一半以上的受访者认为这种行为不道德。超过三分之二的受访者支持制定更严格的法规。结论YDJ 实现了大量的用户参与，嵌入式问卷调查显示，用户普遍对制药公司向医疗保健行业的价值转移持批评观点。尤其是非医疗保健或行业受访者对这种关系表达了最消极的看法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Health Policy and Technology Medicine-Health Policy

CiteScore

9.20

自引率

3.30%

发文量

审稿时长

88 days

期刊介绍： Health Policy and Technology (HPT), is the official journal of the Fellowship of Postgraduate Medicine (FPM), a cross-disciplinary journal, which focuses on past, present and future health policy and the role of technology in clinical and non-clinical national and international health environments. HPT provides a further excellent way for the FPM to continue to make important national and international contributions to development of policy and practice within medicine and related disciplines. The aim of HPT is to publish relevant, timely and accessible articles and commentaries to support policy-makers, health professionals, health technology providers, patient groups and academia interested in health policy and technology. Topics covered by HPT will include: - Health technology, including drug discovery, diagnostics, medicines, devices, therapeutic delivery and eHealth systems - Cross-national comparisons on health policy using evidence-based approaches - National studies on health policy to determine the outcomes of technology-driven initiatives - Cross-border eHealth including health tourism - The digital divide in mobility, access and affordability of healthcare - Health technology assessment (HTA) methods and tools for evaluating the effectiveness of clinical and non-clinical health technologies - Health and eHealth indicators and benchmarks (measure/metrics) for understanding the adoption and diffusion of health technologies - Health and eHealth models and frameworks to support policy-makers and other stakeholders in decision-making - Stakeholder engagement with health technologies (clinical and patient/citizen buy-in) - Regulation and health economics

文献相关原料

公司名称	产品信息	采购帮参考价格